A qualitative study to identify barriers and facilitators to implementation of pilot interventions in the Veterans Health Administration (VHA) Northwest network

Worldviews on Evidence-Based Nursing

Volumn 1, Issue 2, 2004, Pages 129-139

  Sharp, Nancy D ^a   Pineros, Sandra L ^b   Hsu, Clarissa ^c   Starks, Helene ^a   Sales, Anne E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Group Health Community Foundation   (United States)

Author keywords

Cardiovascular disease; Evidence based practice; Interventions; Qualitative study

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATTITUDE TO HEALTH; BLOOD; COOPERATION; CORONARY ARTERY DISEASE; EDUCATION; EVIDENCE BASED MEDICINE; FOLLOW UP; GOVERNMENT; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HUMAN; HYPERCHOLESTEROLEMIA; MASS COMMUNICATION; NEEDS ASSESSMENT; NURSING METHODOLOGY RESEARCH; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PILOT STUDY; PUBLIC RELATIONS; QUALITATIVE RESEARCH; QUESTIONNAIRE; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; CHOLESTEROL, LDL; COOPERATIVE BEHAVIOR; CORONARY DISEASE; DIFFUSION OF INNOVATION; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERCHOLESTEROLEMIA; INTERPROFESSIONAL RELATIONS; NEEDS ASSESSMENT; NURSING METHODOLOGY RESEARCH; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PILOT PROJECTS; PLANNING TECHNIQUES; QUALITATIVE RESEARCH; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; TOTAL QUALITY MANAGEMENT; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; WASHINGTON;

EID: 26844468075     PISSN: 1545102X     EISSN: 17416787     Source Type: Journal    
DOI: 10.1111/j.1741-6787.2004.04023.x     Document Type: Article

References (23)

1. American Heart Association. (2001). Heart disease and stroke statistics-2002 update. Dallas, Texas: American Heart Association. Retrieved May 10, 2002, from http://www.americanheart.org/statistics/coronary.html.
2. Bero L.A., Grilli R., Grimshaw J.M., Harvey E., Oxman A.D. & Thomson M.A. (1998). Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. British Medical Journal, 317(7156), 465-468.
3. Danias P.G., O'Mahony S., Radford M.J., Korman L. & Silverman D.I. (1998). Serum cholesterol levels are underevaluated and undertreated. American Journal of Cardiology, 81, 1353-1356.
4. Effken J.A. & Stetler C.B. (1997). Impact of organizational redesign. Journal of Nursing Administration, 27(7-8), 23-32.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association, 285(19), 2486-2497.
6. Grol R. & Grimshaw J. (1999). Evidence-based implementation of evidence-based medicine. The Joint Commission Journal on Quality Improvement, 25(10), 503-513.
7. Hulscher M.E.J.L., Wensing M., Van der Weijden T. & Grol R. (2001). Interventions to implement prevention in primary care (Cochrane Review). In The Cochrane Library, Issue 2. Oxford: Update Software.
8. Johnston G., Crombie I.K., Davies H.T.O., Alder E.M. & Millard A. (2000). Reviewing audit: Barriers and facilitating factors for effective clinical audit. Quality in Health Care, 9(1), 23-36.
9. Kitson A., Harvey G. & McCormack B. (1998). Enabling the implementation of evidence based practice: A conceptual framework. Quality in Health Care, 7(3), 149-158.
10. Kitson A., Ahmed L.B., Harvey G., Seers K. & Thompson D.R. (1996). From research to practice: One organizational model for promoting research-based practice. Journal of Advanced Nursing, 23(3), 430-440.
11. The LIPID Study Group. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease Study Group. New England Journal of Medicine, 339(19), 1349-1357.
12. Pearson T.A., Laurora I., Chu H. & Kafonek S. (2000). The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Archives of Internal Medicine, 160(4), 459-467.
13. Pedersen T.R., Olsson A.G., Faergeman O., Kjekshus J., Wedel H., Berg K., et al. (1998). Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation, 97(15), 1453-1460.
14. Pineros S.L., Sales A.E., Li Y.-, F. & Sharp N.D. (2004). Improving care to patients with ischemic heart disease: Experiences in a single network of the Veterans Health Administration. Manuscript submitted for publication.
15. Prochaska J.O. & Velicer W.F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion, 12(1), 38-48.
16. Rogers E.M. (1995). Lessons for guidelines from the diffusion of innovations. The Joint Commission Journal on Quality Improvement, 21(7), 324-328.
17. Rogers E.M. (2002). Diffusion of preventive innovations. Addictive Behavior, 27(6), 989-993.
18. Rubenstein L.V., Mittman B.S., Yano E.M. & Mulrow C.D. (2000). From understanding health care provider behavior to improving health care. The QUERI framework for quality improvement. Medical Care, 38, I129-I141.
19. Rycroft-Malone J., Kitson A., Harvey G., McCormack B., Seers K., Titchen A. & Estabrooks C. (2002). Ingredients for change: Revisiting a conceptual framework. Quality and Safety in Health Care, 11(2), 174-180.
20. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine, 335(14), 1001-1009.
21. Scandinavian Simvastatin Survival Study Group. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). The Lancet, 344(8934), 1383-1389.
22. Sloan K.L., Sales A.E., Willems J.P., Every N.R., Martin G.V., Sun H., Pineros S. & Sharp N. (2001). Frequency of serum low-density lipoprotein cholesterol measurement and frequency of this measurement <100mg/dl among patients having had coronary events (Northwest VA Network Study). American Journal of Cardiology, 88, 1143-1146.
23. Wilkinson E.K., McColl A., Exworthy M., Roderick P., Smith H., Moore M., et al. (2000). Reactions to the use of evidence-based performance indicators in primary care: A qualitative study. Quality and Safety in Health Care, 9(3), 166-174.